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A major problem in clinical lung transplantation is the shortage of donor lungs. Only about 20% of donor lungs are accepted
for transplantation. We have recently reported the results of the ﬁrst six double lung transplantations performed with donor
lungs reconditioned ex vivo that had been deemed unsuitable for transplantation by the Scandiatransplant, Eurotransplant, and
UK Transplant organizations because the arterial oxygen pressure was less than 40kPa. The three-month survival of patients
undergoing transplant with these lungs was 100%. One patient died due to sepsis after 95 days, and one due to rejection after 9
months. Four recipients are still alive and well 24 months after transplantation, with no signs of bronchiolitis obliterans syndrome.
Thedonorlungswerereconditioned exvivoinanextracorporeal membraneoxygenation circuitusingSTEENsolutionmixedwith
erythrocytes, to dehydrate edematous lung tissue. Functional evaluation was performed with deoxygenated perfusate at diﬀerent
inspired fractions of oxygen. The arterial oxygen pressure was signiﬁcantly improved in this model. This ex vivo evaluation model
isthusavaluable addition tothearmamentarium inincreasingthenumber ofacceptable lungs ina donorpopulation with inferior
arterial oxygen pressure values, thereby, increasing the lung donor pool for transplantation. In the following paper we present our
clinical experience from the ﬁrst six patients in the world. We also present the technique we used in detail with ﬂowchart.
1.Background
Much eﬀort has been devoted worldwide to increasing lung
donor availability. An approach that has met with some
success has been the extension of criteria used to select
donors, for example, including those older than 55 years,
with a smoking history of more than 20 pack years, and
an abnormal chest roentgenogram, a positive Gram stain
for sputum or bronchoalveolar lavage samples, or prolonged
mechanical ventilation. Despite this, people are dying while
waiting for lung transplants, and there is thus an urgent need
to increase the availability of donor lungs [1–3].
In many brain-dead donors, the arterial oxygen tension
deteriorates to unacceptable values before organs can be
harvested [4, 5] .E d e m a t o u sl u n gt i s s u e ,d u et oe x c e s s i v e
intravenous infusion in an attempt to maintain adequate
donor circulation, may contribute to the deterioration of
the gas exchange capacity. Replacement of blood lost during
the donor operation with crystalloid solutions will further
hemodilutethedonorandreducetheplasmacolloidosmotic
(oncotic) pressure [4, 5]. Due to their spongy structure,
the lungs are especially vulnerable to edema under these
conditions [4, 6].
Steen and colleagues have developed a new method for
ex vivo lung evaluation [7, 8], which was used successfully
for the ﬁrst time in humans, when a lung from a non-
heart-beating donor was transplanted at the Department of
CardiothoracicSurgeryatLundUniversityHospital,Sweden,
in 2000 [8]. The method can also be used for recondi-
tioning of marginal and nonacceptable donor lungs [9],2 Journal of Transplantation
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Figure 1: Flowchart showing the ﬁrst part of the ex vivo reconditioning of donor lungs initially rejected donor lungs for clinical
transplantation.Duringtheﬁrstpartoftheprocess,thelungsarenotventilatedandtheperfusatebloodisoxygenated.Thetemperatureofthe
perfusateisgraduallyincreasedwithagradient ≤10◦Cto32 ◦C.Theinitialperfusionﬂowwas50–100mL/min.Theﬂowwasslowlyincreased,
and the pulmonary pressure was kept at ≤20mmHg. The left atrium pressure was maintained at 0mmHg to prevent the development of
edema.
thus increasing the number of potential lungs available for
transplantation. We have recently reported the results of the
ﬁrst six double lung transplantations performed with donor
lungs, reconditioned ex vivo, that were rejected for trans-
plantationbytheScandiatransplant,Eurotransplant,andUK
Transplant organizations [10]. The six patients underwent
double sequential lung transplantation with initially rejected
donor lungs after reconditioning ex vivo.A l ls i xd o u b l el u n g s
had an initial arterial oxygen pressure below 40kPa during
ventilation at 100% oxygen, and a positive end-expiratory
pressure (PEEP) of 5cm H2O before lung harvesting. The
criteria for lungs chosen to undergo reconditioning were
the same as for conventional donor lungs, except that a
lower partial pressure of oxygen in arterial blood (PaO2)
was accepted. To be accepted for transplantation after
reconditioning, the PaO2 at a fraction of inspired oxygen
(FiO2)o f1 . 0w a sr e q u i r e dt ob e5 0 k P ao rh i g h e r ,i n s t e a d
of the normal 40kPa. Three-month survival was 100%. One
patient has since died from sepsis (after 95 days), and one
from rejection after nine months. Four patients are alive and
well two years after transplantation, without any signs of
bronchiolitis obliterans syndrome [10, 11].
In this paper we present our clinical experience from the
ﬁrst six patients in the world to receive such reconditioned
lungs. We also present the technique used in detail with
ﬂowcharts.
2.SetupandPriming
Figure 1(a) shows the perfusion circuit, which consists of
a hard-shell reservoir (Medtronic Nederland, Kerkrade, the
Netherlands), a centrifugal pump (Biomedicus, Bio-Console
550; Electromedics Inc., Grand Rapids, MI), a membrane
oxygenator with a built-in heat exchanger (Qadrox HMO
1011; Jostra AG, Germany), and a leukocyte/arterial ﬁlter
(LG 6; Pall, Newquay, Cornwall, UK). A ﬂow probe (Bio
Probe TX50; Electromedics Inc.), Polytrode oxygen sensor
(pO2; Polystan, Værløse, Denmark), and temperature sen-
sors(SpaceLabsMedicalInc.,Redmond,WashUSA)arealso
included. A photograph of the setup is shown in Figure 1(b).
A 28-French venous cannula was placed with its tip
in the main pulmonary artery (Figure 2). A baby feeding
catheter was placed in the pulmonary artery to measure
the perfusion pressure. During reconditioning, the perfusion
solutionﬂoweddirectlyoutintothelungreconditioningbox.
Therefore, the left atrium pressure was zero. Before starting
perfusion, the pulmonary artery cannula was connected to
the corresponding tube of the extracorporeal circuit, the air
was removed, and the shunt of the circuit was clamped.
The system was primed with 2 liters of STEEN solution
(Vitrolife AB, Lund, Sweden), mixed with 2 units of ABO-
compatible erythrocyte concentrate, that had been irradi-
ated, leukocyte ﬁltered and washed, to a hematocrit ofJournal of Transplantation 3
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Figure 2: Schematic (a) and photograph (b) of the ex vivo
lung reconditioning and evaluation system. The blood leaving
the remaining dorsal part of the left atrium runs freely out into
the box containing the lung. The pulmonary arterial pressure
(PAP) is measured continuously. The left atrium pressure (LAP)
is maintained at 0mmHg. Blood gases are measured in the blood
before and after the lung. The system is primed with STEEN
solution and erythrocyte concentrate.
15%. STEEN solution is a physiological electrolyte solution
containing human serum albumin and dextran. This solu-
tion is a buﬀered, extracellular solution with a composition
designed to provide a colloid osmotic pressure allowing the
physiologicalpressureandﬂowtobemaintainedwithoutthe
development of pulmonary edema [5, 7, 8, 10, 12].
Imipenem (0.5g, Tienam, Merck Sharp & Dohme, Sol-
lentuna, Sweden), insulin (20IU, Actrapid, Novo Nordisk,
Bagsvaerd, Denmark), and heparin (10,000IU, Leo Pharma,
Malm¨ o, Sweden) were added, and isotonic trometamol
(Addex-Tham, Kabi, Sweden) was used to buﬀer the mixed
solution to a temperature-adjusted pH of 7.4 [7, 8, 10, 12].
3. Reconditioning Part1
Figure 3 shows a ﬂowchart of the ﬁrst part of the recondi-
tioning process, during which the lungs are not ventilated,
and the perfusate blood is oxygenated. After removing the
air from the pulmonary artery, slow perfusion (perfusion
pressure ≤ 20mmHg) was started at 25◦C. The initial
temperatureoftheperfusatewas25◦C,sincethetemperature
of the lungs, after taking them out of the box with Perfadex
solution, and after connecting them to the ex vivo circuit,
is approximately 15◦C, and the gradient between the lung
temperature and the temperature of the perfusate is kept
at approximately 10◦C. The temperature in the perfusate
was gradually increased to 32◦C with a gradient of ≤10◦C.
The initial perfusion ﬂow was 50–100mL/min. The ﬂow
was slowly increased, and the pulmonary pressure was kept
at ≤20mmHg. The left atrium pressure was maintained at
0mmHg to prevent the development of edema.
4. Reconditioning Part 2
Figure 4 shows a ﬂowchart describing the second part of the
reconditioning process, during which the lung is ventilated,
and the perfusate blood is oxygenated. Careful ventilation of
the lungs was started (1L/min) when the temperature of the
perfusate leaving the lungs had stabilized at 32◦C, as the ven-
tilation of cold lungs may lead to lung membrane injury [5].
The rate of ventilation was increased by one liter per minute
for every degree increase in temperature of the perfusate
leaving the lungs (i.e., the lung temperature) up to 37◦C,
at which normal ventilation (100mL/kg/min) was reached.
The gases entering the oxygenator were mixed to obtain
temperature-corrected perfusate gas values of pCO2 of 4.5–
5kPa. The FiO2 was maintained at 1.0, and the respiratory
frequency was gradually increased from 5 to 15–20permin.
The perfusion ﬂow was gradually increased and reached full
ﬂow (5-6L/min) at 37◦C. The perfusion ﬂow was limited
by the pulmonary pressure. The pulmonary pressure was
maintainedat≤20mmHg.Whentheperfusatefromthelung
reached 37◦C, normal ventilation (100mL·kg−1·min−1)w a s
given. The PEEP was gradually increased and reached 5cm
H2Oa t3 7 ◦C.
5. Evaluation
Figure 5 shows a ﬂowchart describing lung evaluation, dur-
ing which the lung is fully ventilated and the perfusate blood
is deoxygenated with a mixture containing 93% nitrogen
and 7% CO2 (i.e., the oxygenator is used to deoxygenate
the perfusate), mimicking normal venous blood gas in the
perfusate to the pulmonary artery, to be able to test the lung
function. The PEEP was maintained at 5cm H2O, except
when it was temporarily increased to 8cm H2O to eliminate
atelectasis.
The gases entering the oxygenator were mixed to obtain
perfusate gas values of pCO2 = 4.5–5kPa. At this point, the
rate of perfusion ﬂow was maintained at 5-6L/min (i.e., full
ﬂow). Samples of blood were taken before and after passing
through the lungs (i.e., venous and arterial blood samples)
to measure blood gases after 5 minutes’ exposure to FiO2 of
0.21, 0.5, and, 1.0.
A deﬂation test was then performed, which consists of
observing the lung after the endotracheal tube is suddenly
disconnectedfromtheventilator.Inanormallung,thewhole
lung should be deﬂatied (global atelectasis). If the deﬂation
test was normal and the PO2 at an FiO2 of 1.0 was 50kPa or
higher, the lungs were accepted for transplantation.
The duration of reconditioning and evaluation in the ex
vivo circuit was between 1 and 2 hours.4 Journal of Transplantation
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Figure 3: Flowchart showing the second part of the ex vivo reconditioning of donor lungs initially rejected donor lungs for clinical
transplantation. Duringthe second partof the process,the lungs are ventilated and the perfusate blood is oxygenated. When the temperature
reaches 32◦C, careful ventilation is started at 1L/min. The ventilation rate is increased with one liter per increasing degree of perfusate from
the lung (i.e., increasing lung temperature). The FiO2 was maintained at 1.0, and the respiratory frequency was gradually increased from 5
to 15–20 per min. The perfusion ﬂow was limited by the pulmonary pressure (≤20mmHg). The PEEP was gradually increased to 5cm H2O
at 37◦C.
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Figure 4: Flowchart illustrating the evaluation of ex vivo reconditioned lungs for clinical transplantation. During the evaluation, the lung is
fully ventilated and the perfusate blood is deoxygenated. The gases entering the oxygenator are mixed to obtain values of pCO2 of 4.5–5kPa.
At this point, the perfusion ﬂow was 4–6L/min (i.e., full ﬂow). Samples of the perfusate blood are taken before and after passing through
the lung (i.e., venous and arterial blood samples) after 5 minutes’ exposure to FiO2 of 0.21, 0.5, and 1.0 in order to measure blood gases. A
deﬂation test is then performed. If the deﬂation test is normal and the PaO2 with FiO2 = 1.0 was 50kPa or higher, the lungs are accepted for
transplantation.
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Figure 5: Photograph of the preparation of the donor lungs for ex vivo treatment showing cannulation of the pulmonary artery.Journal of Transplantation 5
6. Cooling and Preservation
When reconditioning and evaluation of the lungs had been
completed, and the surgeon had deemed them acceptable
for transplantation according to the criteria described above,
the lungs were cooled and preserved until the time of
transplantation [13, 14]. The temperature of the ingoing
perfusate was reduced to 25◦C, and when the temperature
had stabilized, perfusion was stopped. The pulmonary artery
cannula and the trachea were clamped with the lungs in
a semi-inﬂated state (FiO2 = 1.0). The lungs were then
immersed in the perfusate, to which a buﬀered Perfadex
solution was added. The extracorporeal circuit was then
used to perfuse the solution through the box containing the
immersedlungs,keepingthemediumoxygenatedandcooled
at 8◦C.
7. Transplantationand Outcome
After ex vivo reconditioning, the initially rejected donor
lungs were transplanted into the patients. Double sequential
lung transplantation was performed, with clam shell incision
in four patients, and bilateral thoracotomy in the other two.
Three patients were females and three were males. Three of
the patients had been diagnosed with COPD, one patient
with cystic ﬁbrosis (CF), one with lung ﬁbrosis, and one with
α1-antitrypsin deﬁciency. The recipients had a median age of
54 years (range 35–64y) at the time of transplantation [10].
The median height was 170cm (range 158–180cm), and the
median weight 76kg (range 55–94kg) [10].
The donors had a median age of 59 years (range 34–
63y), a median height of 173cm (range 154–182cm), and
a median weight of 77kg (range 42–90kg). The cause of
death was cerebral bleeding in four of the donors, and
two donors were resuscitated to spontaneous circulation
after cardiac arrest [10]. A total of nine double lungs were
reconditioned ex vivo. Six of them had PaO2 > 50kPa at a
FiO2 of 1.0 after reconditioning ex vivo. These six double
lungs were transplanted, and the other 3 were not used.
All donor lungs showed a normal chest radiograph prior
to harvesting. The median PaO2 of the donors of the six
successfully reconditioned lungs was 21.1kPa (range 11.5–
28.7kPa) at FiO2 = 1.0 before harvesting. The corresponding
values after ex vivo reconditioning were 68.7kPa (range from
51.6 to 79.5) [10]. The median reconditioning time was 1
h o u r2 9m i n u t e s( r a n g e ,1h o u r6m i n u t e st o2h o u r s1
minute) [10]. The time from harvesting to connection to
the ex vivo reconditioning circuit was 6.4 hours (range 5.2–
9.6h), during which the lungs were stored in cold Perfadex
solution. The total median time from lung harvesting to
transplantation was 16.4 hours (range 10.6–17.5h) for the
rightlungand18.0hours(range12.6–21.5h)fortheleftlung
[10].
Three of the six patients were reintubated after extuba-
tion, and one of these had to be reintubated a second time.
The six patients were connected to a respirator for a median
time of 191 hours (range 25–2370h). The patients remained
in the intensive care unit for a median of 13 days (range 4–
99d), and the median length of hospital stay was 52 days
(range 45–99d) [11].
Three-month survival was 100%. One patient died due
to sepsis, after 95 days, and one due to the rejection of the
transplant after 9 months. The four patients surviving to the
12-month control showed increased 6-minute walking test
values compared with the 3-month control, while the forced
expiratory volume of air during 1 second increased in 3 and
was the same in 1 patient. These four recipients are alive and
well, without any signs of bronchiolitis obliterans syndrome,
24 months after the transplantation [10].
8. Comments
In the present paper, we present our clinical experience from
the ﬁrst six patients undergoing double lung transplantation,
with ex vivo reconditioned donor lungs initially considered
unacceptable for transplantation. We also present the recon-
ditioning method and evaluation in detail with ﬂowchart.
All the lungs had been rejected by transplantation centers,
both national and international, due to low PaO2 (<40kPa)
after 5 minutes’ ventilation with 5 PEEP using 100% oxygen.
The lungs were reconditioned and evaluated immediately
upon arrival at the department. If arrival time was before 11
pm, reconditioning and evaluation were performed followed
by immediate double lung transplantation. Lungs arriving
after 11 pm were reconditioned and evaluated, and were
then cooled, and transplantation was started at 8 am on the
following day to avoid night-time surgery.
WeprimedthesystemwithSTEENsolutionandbloodto
a hematocrit of 15%, since all preclinical studies performed
on animals by Professor Stig Steen at our department have
beencarriedoutwiththiskindofpriming.Whenperforming
the ﬁrst clinical trials on humans, we believed it advisable
to use the same priming as in the preclinical studies [7, 8].
It may be possible to prime the machine in other ways with
other solutions, or blood, but we have no such data.
In patients where the total period of lung ischemia
(before reconditioning, reconditioning, evaluation, and
after evaluation) exceeded 17-18 hours, we found that
even if the criteria for extubation regarding normal chest
roentgenogram and excellent blood gases were fulﬁlled one
to two days after surgery, they were not ready for extubation.
If extubation was performed at this time, re-intubation
and connection to a ventilator were often necessary a few
hours later. We believe that half the ﬂuid balance must be
withdrawn from patients in this situation, and that one must
wait at least two days after surgery, in addition to applying
the conventional criteria for extubation, before extubation
anddisconnectionfromtheventilatorarepossible.Wefound
that postoperative chest roentgenogram of the reconditioned
lungs showed slightly increased vessel width and a tendency
towards edema, which may indicate some kind of membrane
injury in the lung parenchyma although the blood gas
values were comparable to those in lungs not subjected to
reconditioning prior to transplantation.
Double lung transplantation was carried out in all six
patients, in order to be able to evaluate the reconditioning
procedure.Insinglelungtransplantation,bloodmaybecome
oxygenated by the remaining native lung, making it diﬃcult
to evaluate the success of transplanting reconditioned lungs.6 Journal of Transplantation
All lung donors were free from pulmonary disease, and
were not using any medication. The main reason for initial
rejection of the lungs by the transplantation team was poor
blood gas levels. Poor oxygenation in brain-dead donors
connected to a ventilator is often the result of pulmonary
edema, atelectasis, lung emboli or aspiration. All these
conditions are well-known causes of a rapid decrease in
oxygenation capacity.
Withtheexvivoreconditioningandevaluationtechnique
describedhere,wewereableto“treat”pulmonaryedemaand
eliminate atelectasis. It was also possible to carry out careful
suction in the bronchus to minimize the eﬀects of aspiration.
Using the technique described in the present paper,
we were able to “treat” pulmonary edema and atelectasis
in the donor lungs and reevaluate their suitability for
transplantation. The technique had not previously been
used clinically on humans, and we increased the limit for
acceptance for transplantation from the golden standard of
PO2 > 40kPa to >50kPa after 5 minutes of ventilation with
5 PEEP. There was no evidence for this increased level, but it
was adopted to increase the safety margin.
Based on our ﬁndings and experience, we would like
to make the following two important recommendations
to other cardiothoracic transplantation centers considering
such an ex vivo lung reconditioning process to increase the
number of donor lungs available for transplantation.
(I) Perform the transplantation immediately, or as soon
as possible, after reconditioning and evaluation to
limit the duration of ischemia. We encourage a
careful attitude towards increasing ischemic time
to an already marginal donor lung. At the same
time, it would be an advantage, to both the surgeon
and the patient, if night-time surgery could be
avoided. Promising results have been obtained from
experimental studies in pigs, where it was shown
that the lungs and their vascular function could
be safely preserved for up to 24h [13], that the
gas exchange system of the lungs can tolerate 1h
of warm ischemia after circulatory arrest without
signiﬁcant loss of functional capacity, and that the
pulmonary artery can withstand warm ischemia for
3h after death without impairment of endothelium-
dependent relaxation or vascular smooth-muscle
function [15]. Furthermore, it has been demon-
strated that simple topical cooling of nonventilated
lungs provides excellent preservation conditions for
12–24h [13, 14]. However, long-term followup of a
larger patient cohort is necessary before this method
can become a clinical routine.
(II) Do not extubate and disconnect the patient from the
ventilator during the ﬁrst 24 hours after surgery, even
ifthechestX-rayappearsnormal,andthebloodgases
are excellent, that is, the criteria for extubation are
fulﬁlled. We strongly recommend waiting 2-3 days,
and ensuring that at least half of the ﬂuid balance is
withdrawn before extubation is performed.
In normal clinical lung transplantation, poor post-
transplantation function remains a major problem, with
signiﬁcantly impaired function in 10% to 20% of cases [16].
It is, therefore, of the utmost importance to identify these
lungs in advance, especially when using marginal donors.
This method may be useful in the evaluation of marginal
donor lungs as well as lungs from non-heart-beating donors.
Furthermore, this method allows the time between harvest
and transplantation to be increased, thereby allowing better
planning for transplantation. Among other things, this will
allow for the optimization of donor-recipient matching,
for example, with HLA (human leukocyte antigen). We
believe that this ex vivo reconditioning and evaluation model
provides a valuable addition to the armamentarium for
ﬁnding acceptable lungs in a donor population with inferior
PaO2 values. However, as always, donor selection comes
down to sound clinical judgment based on all the available
data.
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